Connection

GLENN CUNNINGHAM to Dihydrotestosterone

This is a "connection" page, showing publications GLENN CUNNINGHAM has written about Dihydrotestosterone.
Connection Strength

0.569
  1. Prostatein C3-mRNA: a sensitive marker of androgen-responsiveness in prostate explant cultures. Prostate. 1990; 17(1):41-55.
    View in: PubMed
    Score: 0.082
  2. Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels. JAMA. 1989 May 05; 261(17):2525-30.
    View in: PubMed
    Score: 0.079
  3. Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer. J Urol. 2007 Oct; 178(4 Pt 1):1521-7.
    View in: PubMed
    Score: 0.070
  4. Acid phosphatase activity: a marker of androgen action in prostate explant cultures. Prostate. 1987; 10(1):69-77.
    View in: PubMed
    Score: 0.067
  5. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004 May; 89(5):2179-84.
    View in: PubMed
    Score: 0.056
  6. Characterization of steroid binding specificity of the androgen receptor in human foreskin fibroblasts. Steroids. 1983 May; 41(5):617-26.
    View in: PubMed
    Score: 0.052
  7. Lovastatin-induced apoptosis in prostate stromal cells. J Clin Endocrinol Metab. 1997 May; 82(5):1434-9.
    View in: PubMed
    Score: 0.034
  8. Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men. J Clin Endocrinol Metab. 1995 Jun; 80(6):1934-40.
    View in: PubMed
    Score: 0.030
  9. 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations. J Androl. 1991 Sep-Oct; 12(5):315-22.
    View in: PubMed
    Score: 0.023
  10. Testosterone replacement therapy and sleep-related erections in hypogonadal men. J Clin Endocrinol Metab. 1990 Mar; 70(3):792-7.
    View in: PubMed
    Score: 0.021
  11. New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab. 2004 Aug; 89(8):3821-9.
    View in: PubMed
    Score: 0.014
  12. Steroid structural requirements for high affinity binding to human sex steroid binding protein (SBP). Steroids. 1981 Sep; 38(3):243-62.
    View in: PubMed
    Score: 0.012
  13. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab. 2000 Dec; 85(12):4500-10.
    View in: PubMed
    Score: 0.011
  14. Differences in steroid specificity for rat androgen binding protein and the cytoplasmic receptor. Steroids. 1979 Mar; 33(3):261-76.
    View in: PubMed
    Score: 0.010
  15. 5alpha-Dihydrotestosterone binding to androgen binding protein. Effects of testosterone and other compounds in vivo and in vitro on the number of binding sites measured. J Biol Chem. 1978 Jan 10; 253(1):166-9.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.